








People Who Use Drugs and Mental Health 
 
Ongoing discussions, including among key 
international donors, have raised concerns 
within Harm Reduction International and the 
International Network of People who Use 
Drugs (INPUD) about the proposed inclusion of 
mental health within the harm reduction 
package and more generally about conflating 
drug use and mental health. This paper aims to 
stimulate and clarify the discussion around this.  
 
Although there are people who use drugs who 
may experience mental health issues, drug use 
and drug dependency itself is not a mental 
health condition. The concerning conflation of 
drug use and dependency with mental health 
issues is inaccurate, stigmatising and might 
have long term harmful consequences to the 
community, including removing the agency and 
capacity of people who use drugs to make 
decisions about their own bodies and lives. It 
could reduce resources available for harm 
reduction and community-led services, and 
lead to deprioritizing evidence-based, 
lifesaving public health interventions in 
national and international guidelines. A lack of 
political will and insufficient funding are major 
barriers to implementing harm reduction at 
scale, and this conflation could seriously 
disrupt availability, access and delivery of 
essential services.  
 
Despite there being virtually no data to support 
it, the notion that drug “addiction” is a brain 
disease provides an attractive narrative that is 
simple and reassuring. This theory contributes 
to unrealistic, costly, and harmful drug policies, 
and removes any consideration of the role of 
socioeconomic factors such as poverty, 
homelessness, and race. It also ignores the 
stigmatising effect of the drug “addiction” 
construct.  
 
Over the past decades, we have been able to 
somewhat shift from a solely biological, 
medicalised approach to drug use focusing on 
personal responsibilities, towards a more 
holistic approach acknowledging the social and 
structural aspects of drug use. The new 
approach recognises that drug related harms 
are not distributed evenly throughout society, 
but disproportionately affect stigmatised and 
marginalised communities. Conflating mental 
health problems and drug use is a huge step 
back from this progress. 
 
The inclusion of ‘substance use disorder’ in the 
fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-V) 
misrepresents drug use. The term “substance 
use disorder” blurs together mental health 
issues with drug use and/or drug dependency 
and has the effect of alienating people who use 
drugs who would not conflate their drug use 
with any form of “disorder”. At the core of the 
DSM-V definition is the idea that drug use 
“disorders” are due to changes in the brain, 
while the definition itself uses 11 criteria to 
measure the “disorder”. These criteria relate to 
social functioning, social compliance and 




do what you should at work, home, or school 
because of substance use” and/or “giving up 
important social, occupational, or recreational 
activities because of substance use”), alongside 
other indicators related to the physical effects 
of the drugs (e.g. tolerance, withdrawal).  
 
INPUD prefers “drug dependency,” a term that 
is used by the United Nations Office on Drugs 
and Crime (UNODC) and the International 
Statistical Classification of Diseases (ICD), both 
for its more neutral associations and for the 
fact that it distinguishes between physical, 
physiological and psychological dependence. 
The term encompasses the difference between 
these forms, which the pathologizing 
“substance use disorder” fails to do. 
 
Mental health issues can occur alongside drug 
use or drug dependency, but this does not 
indicate that they are always either a result of 
drug use nor preface drug use. It is important 
to underline that mental health issues and drug 
dependency can emerge from the same 
structural factors, like poverty, lack of access to 
healthcare and other services, homelessness, 
and stigma and discrimination. In some, not all, 
cases, people start or continue using drugs to 
deal with mental health issues, and in some 
instances, drugs can help people to manage 
their mental health symptoms, as well as life’s 
challenges.  
 
People who use drugs, like all people, should 
have appropriate access to mental health 
support as needed. We have to find ways to 
encourage better access to mental health 
services for people who use drugs without 
framing drug use and/or dependence as mental 
health issues in absolute terms. Furthermore, 
we must seek to continually challenge ideas 
that pathologise drug use and people who use 
drugs that deny will and agency to people who 
use drugs, removing the right to make choices 
regarding their physical and mental health. 
People who use drugs consume substances for 
a variety of reasons, including for the rational 
pursuit of pleasure and regulation of emotions. 
We must find better models that embrace the 
complexity and multitude of rationalities for 
drug use and dependency; and continue to 
question and challenge simplistic models that 
could potentially constitute more harm and 
damage.  
 
With this short discussion paper HRI and INPUD 
want to generate an evidence-based, and 
productive discussion around these issues and 
the risks of conflating drug use and mental 
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